Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema

Phase 3 Completed 46 enrolled Pfizer

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study will asses sthe safety of pegaptanib sodium in patients with diabetic macular edema. The hypothesis is that pegaptanib is safe and efficacious in patients with diabetic macular edema.

Timeline

Start: 2011-01
Primary completion: 2012-07
Completion: 2012-07

Publications

Sivaprasad S, Browning RC, Starita C. An open-label, one-year, noncomparative study to evaluate the safety and tolerability of intravitreal pegaptanib sodium in patients with diabetic macular edema. Clin Ophthalmol. 2014 Aug 21;8:1565-71. doi: 10.2147/OPTH.S68498. eCollection 2014.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	pegaptanib sodium	Aptamer	0.3 mg	Other

Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema

Summary

Timeline

Publications

Drugs

Indications